Molecular Templates Ownership | Who Owns Molecular Templates?
Molecular Templates Ownership Summary
Molecular Templates is owned by 42.68% institutional investors, and 57.32% retail investors. BB Biotech AG Ord is the top mutual fund, with 19.44% of its assets in Molecular Templates shares.
MTEM Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Molecular Templates | 42.68% | - | 57.32% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2023 | 37 | 2.78% | 24,049,301 | -1.58% | 42 | 2.27% | 9 | 12.50% | 9 | 12.50% |
Mar 31, 2023 | 36 | -23.40% | 24,435,575 | -13.04% | 43 | 1.74% | 8 | -46.67% | 8 | -50.00% |
Dec 31, 2022 | 47 | -4.08% | 28,100,556 | -10.06% | 49 | 1.62% | 15 | 87.50% | 16 | -27.27% |
Sep 30, 2022 | 49 | -15.52% | 31,242,458 | -4.53% | 55 | 1.64% | 8 | -73.33% | 22 | 29.41% |
Jun 30, 2022 | 58 | -24.68% | 32,725,861 | -9.46% | 58 | 1.41% | 30 | - | 17 | -45.16% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
BB Biotech AG Ord | 1.28M | 19.44% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 49.89K | 0.76% | - |
Fidelity Extended Market Index | 29.85K | 0.45% | 1.99K |
Fidelity Series Total Market Index | 7.02K | 0.11% | 3.14K |
BlackRock Extended Equity Market K | 6.59K | 0.10% | -3.00 |
Northern Trust Extended Eq Market Idx | 5.06K | 0.08% | - |
NT Ext Equity Mkt Idx Fd - L | 5.06K | 0.08% | - |
Fidelity Total Market Index | 3.96K | 0.06% | - |
Fidelity Nasdaq Composite Index | 3.48K | 0.05% | - |
NT Ext Equity Mkt Idx Fd - NL | 2.46K | 0.04% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 14, 2024 | BIOTECH TARGET N V | - | Sell | $845.83K |
Apr 02, 2024 | BIOTECH TARGET N V | - | Buy | $134.67 |
Apr 02, 2024 | BIOTECH TARGET N V | - | Buy | $1.81M |
Apr 02, 2024 | BIOTECH TARGET N V | - | Buy | $587.50K |
Jul 17, 2023 | BIOTECH TARGET N V | - | Buy | $2.00M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | 3 | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
2023 Q3 | 1 | - |
2023 Q1 | - | - |
MTEM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools